PXMTF (PHAXIAM Therapeutics) Institutional Ownership: 0.41% (As of Jun. 30, 2026)


PXMTF PHAXIAM Therapeutics SA PXMTF
38 GF Score
Price $0.00
View Full Analysis

What is PHAXIAM Therapeutics Institutional Ownership?

PHAXIAM Therapeutics PXMTF 38 Institutional Ownership is 0.41% as of Jun. 30, 2026. GuruFocus rates PXMTF with a GF Score™ of 38/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PHAXIAM Therapeutics's institutional ownership is 0.41%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PHAXIAM Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PHAXIAM Therapeutics's Float Percentage Of Total Shares Outstanding is 99.98%.

PHAXIAM Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for PHAXIAM Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PHAXIAM Therapeutics Institutional Ownership Chart

PHAXIAM Therapeutics Historical Data

The historical data trend for PHAXIAM Therapeutics can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 0.25 1.04 1.04 1.04 1.04 1.02 1.43 1.43 1.32 0.48
PXMTF
38GF Score
PHAXIAM Therapeutics SA PXMTF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PHAXIAM Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.41% mean?
PHAXIAM Therapeutics (PXMTF) has a Institutional Ownership of 0.41% as of Jun. 30, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on PHAXIAM Therapeutics and its competitors.
Is PHAXIAM Therapeutics' Institutional Ownership too high?
PHAXIAM Therapeutics' current Institutional Ownership is 0.41%. Overall, PHAXIAM Therapeutics has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does PHAXIAM Therapeutics' Institutional Ownership compare to VRTX and REGN?
PHAXIAM Therapeutics' Institutional Ownership of 0.41% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on PHAXIAM Therapeutics and its competitors. PHAXIAM Therapeutics's current Institutional Ownership is 0.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PHAXIAM Therapeutics stock overvalued right now?
PHAXIAM Therapeutics (PXMTF) has a current Institutional Ownership of 0.41%. The current Institutional Ownership is 0.41%. PHAXIAM Therapeutics' overall GF Score™ is 38/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For PHAXIAM Therapeutics (PXMTF), the current Institutional Ownership is 0.41% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PHAXIAM Therapeutics Business Description

Address 60 Avenue Rockefeller, Lyon, FRA, 69008
PHAXIAM Therapeutics SA is a clinical-stage biopharmaceutical company developing therapies for severe forms of cancer and orphan diseases. Its platform uses a novel technology to encapsulate therapeutic drug substances inside erythrocytes, or red blood cells, or RBC. It is developing a pipeline of product candidates for patients with high unmet medical needs. Its product candidate eryaspase, also referred to as GRASPA, targets the metabolism of cancer cells by depriving the cells of asparagine, an amino acid necessary for their survival and critical in maintaining the cells' rapid growth rate. The company is developing for the treatment of severe tumors, including pancreatic cancer, acute lymphoblastic leukemia, or ALL, and triple-negative breast cancer, or TNBC.
38GF Score

Get the complete analysis for PXMTF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price